Cargando…

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study

BACKGROUND: Type 1 diabetes (T1D) is a chronic, autoimmune and multifactorial disease characterized by abnormal metabolism of carbohydrate and fat. Diminished carnitine plasma levels have been previously reported in T1D patients and carnitine increases the sensitivity of the cells to insulin. Polymo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago, Jose Luis, Martínez, Alfonso, de la Calle, Hermenegildo, Fernández-Arquero, Miguel, Figueredo, M Ángeles, de la Concha, Emilio G, Urcelay, Elena
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513557/ https://www.ncbi.nlm.nih.gov/pubmed/16796743 http://dx.doi.org/10.1186/1471-2350-7-54

Ejemplares similares

Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population
por: Santiago, Jose Luis, et al.
Publicado: (2007)

A functional PTPN22 polymorphism associated with several autoimmune diseases is not associated with IgA deficiency in the Spanish population
por: Núñez, Concepción, et al.
Publicado: (2006)

Type 1 Diabetes in the Spanish Population: additional factors to Class II HLA-DR3 and -DR4
por: Urcelay, Elena, et al.
Publicado: (2005)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
por: Chen, Peixian, et al.
Publicado: (2022)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

Interleukin-10 polymorphisms in Spanish IgA deficiency patients: a case-control and family study
por: Ortiz, Javier, et al.
Publicado: (2006)

Early B-cell Factor gene association with multiple sclerosis in the Spanish population
por: Martínez, Alfonso, et al.
Publicado: (2005)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

Interleukin-10 haplotypes in Celiac Disease in the Spanish population
por: Núñez, Concepción, et al.
Publicado: (2006)

Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions
por: Lu, Hang, et al.
Publicado: (2017)

Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort
por: Vávra, Jiří, et al.
Publicado: (2022)

Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8)
por: Wang, Li, et al.
Publicado: (2012)

Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases
por: Martínez, Alfonso, et al.
Publicado: (2008)

Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018)

Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma
por: Ekizoglu, Seda, et al.
Publicado: (2018)

Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer
por: Ren, Anjing, et al.
Publicado: (2019)

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
por: Ningrum, Vitarani Dwi Ananda, et al.
Publicado: (2022)

Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins
por: Lee, Woon Kyu, et al.
Publicado: (2006)

Genetic and Epigenetic Regulation of the Organic Cation Transporter 3, SLC22A3
por: Chen, Ligong, et al.
Publicado: (2012)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
por: Ahn, Seong Kyu, et al.
Publicado: (2015)

Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay
por: Reid, Emma S., et al.
Publicado: (2017)

Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes
por: Cha, Do Hyeon, et al.
Publicado: (2019)

Effect of Cholesterol on the Organic Cation Transporter OCTN1 (SLC22A4)
por: Pochini, Lorena, et al.
Publicado: (2020)

An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer
por: Wei, Jianming, et al.
Publicado: (2020)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout
por: Pavelcova, Katerina, et al.
Publicado: (2020)

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene
por: Zhou, Yunguo, et al.
Publicado: (2023)

Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
por: Jakoby, Michael, et al.
Publicado: (2021)

Identification of SLC22A5 Gene Mutation in a Family with Carnitine Uptake Defect
por: Mutlu-Albayrak, Hatice, et al.
Publicado: (2015)

Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer
por: Jung, Yeonjoo, et al.
Publicado: (2015)

The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients
por: Noguera-Uclés, José Francisco, et al.
Publicado: (2020)

Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety
por: Soria-Chacartegui, Paula, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88ecl51h7sl77cdg2j6s7um9tm